Article 31 Jan 2025 T 1418/22: Acalabrutinib Provides Guidance On Establishing Inventiveness Of Polymorphs At The EPO United Kingdom IP
Article 31 Jan 2025 T 0295/22: Apremilast Decision Highlights Hopes And Challenges For Broad Second Medical Use Claims United Kingdom IP